Skip to main content
logo
Argent BioPharma Limited (ASX:RGT)
Australia flag Australia · Delayed Price · Currency is AUD
0.0380
-0.0030 (-7.32%)
Aug 11, 2026, 3:56 PM AEST

Argent BioPharma Ratios and Metrics

Millions AUD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Market Capitalization
5614174485
Market Cap Growth
-13.55%-56.96%-18.92%-61.62%-48.94%171.31%
Enterprise Value
111416254086
Last Close Price
0.040.080.305.0016.0037.00

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
PS Ratio
13.1032.3815.244.959.2328.54
PB Ratio
-0.54-0.68-2.33-2.098.436.18
P/TBV Ratio
----16.2212.60

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
EV/Sales Ratio
30.5580.2018.037.388.3828.72

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Debt / Equity Ratio
-0.90-0.96-1.67-1.210.840.44
Net Debt / Equity Ratio
-0.72-0.84-1.55-1.180.480.04
Net Debt / EBITDA Ratio
-0.62-0.48-0.53-0.65-0.16-0.05
Net Debt / FCF Ratio
-0.80-0.78-0.61-0.78-0.17-0.04
Asset Turnover
0.140.030.090.240.220.19
Inventory Turnover
-1.551.071.273.082.98
Quick Ratio
0.190.130.100.060.501.27
Current Ratio
0.210.190.230.190.841.55
Return on Equity (ROE)
-----218.54%-187.61%
Return on Assets (ROA)
-243.04%-147.52%-108.46%-66.60%-45.27%-46.40%
Return on Capital Employed (ROCE)
139.30%187.10%1297.80%454.20%-142.80%-65.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Earnings Yield
-189.17%-305.20%-129.05%-124.29%-46.61%-18.56%
FCF Yield
-167.12%-158.75%-108.97%-72.67%-34.02%-17.91%
Buyback Yield / Dilution
-37.70%-54.47%-1155.86%-14.85%-34.63%-37.91%